References
- Aaron, E., Blum, C., Seidman, D., Hoyt, M. J., Simone, J., Sullivan, M., & Smith, D. K. (2018). Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care and STDs, 32(1), 16–23. https://doi.org/https://doi.org/10.1089/apc.2017.0201
- AIDSVu. (n.d.). Mapping PrEP: First ever data on PrEP users across the U.S. Retrieved November 5, 2019, from https://aidsvu.org/prep/
- Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care and STDs, 29(2), 102–110. https://doi.org/https://doi.org/10.1089/apc.2014.0142
- Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., Ronald, A., Tumwesigye, E., Were, E., Fife, K. H., Kiarie, J., Farquhar, C., John-Stewart, G., Kakia, A., Odoyo, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. https://doi.org/https://doi.org/10.1056/NEJMoa1108524
- Birkhead, G. S., Pulver, W. P., Warren, B. L., Hackel, S., Rodríguez, D., & Smith, L. (2010). Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002–2006. Obstetrics and Gynecology, 115(6), 1247–1255. https://doi.org/https://doi.org/10.1097/AOG.0b013e3181e00955
- Blackstock, O. J., Patel, V. v., Felsen, U., Park, C., & Jain, S. (2017). Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic. AIDS Care, 29(7), 866–869. https://doi.org/https://doi.org/10.1080/09540121.2017.1286287
- Bowser, M., Young, R. M., Nesbitt, L. S., & Kharfen, M. (2020). Annual epidemiology & surveillance report. Data through December 2019. District of Columbia Department of Health HAHSTA. www.dchealth.dc.gov/hahsta
- Bradley, E., Forsberg, K., Betts, J. E., DeLuca, J. B., Kamitani, E., Porter, S. E., Sipe, T. A., & Hoover, K. W. (2019). Factors affecting pre-exposure prophylaxis implementation for women in the United States: A systematic review. Journal of Women’s Health (2002), 28(9), 1272–1285. https://doi.org/https://doi.org/10.1089/jwh.2018.7353
- Calabrese, S. K., Dovidio, J. F., Tekeste, M., Taggart, T., Galvao, R. W., Safon, C. B., Willie, T. C., Caldwell, A., Kaplan, C., & Kershaw, T. S. (2018). HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend planned parenthood. JAIDS Journal of Acquired Immune Deficiency Syndromes, 79(1), 46–53. https://doi.org/https://doi.org/10.1097/QAI.0000000000001762
- Castel, A.D., Feaster, D.J., Tang, W., Willis, S., Jordan, H., Villamizar, K., Kharfen, M., Kolber, M.A., Rodriguez, A., & Metsch, L. R. (2015). Understanding HIV care provider attitudes regarding intentions to prescribe PrEP. JAIDS Journal of Acquired Immune Deficiency Syndromes, 70(5), 520–528. https://doi.org/https://doi.org/10.1097/QAI.0000000000000780
- CDC. (n.d.). PrEP | HIV basics | HIV/AIDS. Retrieved January 16, 2020, from https://www.cdc.gov/hiv/basics/prep.html
- Committee on Gynecologic Practices. (2014). Preexposure prophylaxis for the prevention of human immunodeficiency virus. Obstetrics and Gynecology, 123(5), 1133–1136. https://doi.org/https://doi.org/10.1097/01.AOG.0000446855.78026.21
- Drake, A. L., Wagner, A., Richardson, B., & John-Stewart, G. (2014). Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: A systematic review and meta-analysis. PLoS Medicine, 11(2), e1001608. https://doi.org/https://doi.org/10.1371/journal.pmed.1001608
- Fishbein, M. (2009). An integrative model for behavioral prediction and its application to health promotion. https://psycnet.apa.org/record/2009-19878-008
- Fishbein, M., & Ajzen, I. (2010). Predicting and changing behavior: The reasoned action approach. Psychology Press.
- Flynn, P. M., Mirochnick, M., Shapiro, D. E., Bardeguez, A., Rodman, J., Robbins, B., Huang, S., Fiscus, S. A., van Rompay, K. K. A., Rooney, J. F., Kearney, B., Mofenson, L. M., Watts, D. H., Jean-Philippe, P., Heckman, B., Thorpe, E., Cotter, A., Purswani, M., & PACTG 394 Study Team. (2011). Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants. Antimicrobial Agents and Chemotherapy, 55(12), 5914–5922. https://doi.org/https://doi.org/10.1128/AAC.00544-11
- Garfinkel, D. B., Alexander, K. A., McDonald-Mosley, R., Willie, T. C., & Decker, M. R. (2017). Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care, 29(6), 751–758. https://doi.org/https://doi.org/10.1080/09540121.2016.1234679
- Goparaju, L., Praschan, N. C., Jeanpiere, L. W., Experton, L. S., Young, M. A., & Kassaye, S. (2017). Stigma, partners, providers and costs: Potential barriers to PrEP uptake among US women. Journal of AIDS & Clinical Research, 8(9). https://doi.org/https://doi.org/10.4172/2155-6113.1000730
- Gray, R. H., Li, X., Kigozi, G., Serwadda, D., Brahmbhatt, H., Wabwire-Mangen, F., Nalugoda, F., Kiddugavu, M., Sewankambo, N., Quinn, T. C., Reynolds, S. J., & Wawer, M. J. (2005). Increased risk of incident HIV during pregnancy in Rakai, Uganda: A prospective study. The Lancet, 366(9492), 1182–1188. https://doi.org/https://doi.org/10.1016/S0140-6736(05)67481-8
- Groer, M., El-Badri, N., Djeu, J., Harrington, M., & van Eepoel, J. (2010). Suppression of natural killer cell cytotoxicity in postpartum women. American Journal of Reproductive Immunology (New York, N.Y. : 1989), 63(3), 209–213. https://doi.org/https://doi.org/10.1111/j.1600-0897.2009.00788.x
- Hapgood, J. P., Kaushic, C., & Hel, Z. (2018). Hormonal contraception and HIV-1 acquisition: Biological mechanisms. Endocrine Reviews, 39(1), 36–78. https://doi.org/https://doi.org/10.1210/er.2017-00103
- Heffron, R., Mugo, N., Hong, T., Celum, C., Marzinke, M. A., Ngure, K., Asiimwe, S., Katabira, E., Bukusi, E. A., Odoyo, J., Tindimwebwa, E., Bulya, N., Baeten, J. M., & Partners Demonstration Project and the Partners PrEP Study Teams. (2018). Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention. Aids (london, England), 32(12), 1707–1713. https://doi.org/https://doi.org/10.1097/QAD.0000000000001867
- Heffron, R., Ngure, K., Odoyo, J., Bulya, N., Tindimwebwa, E., Hong, T., Kidoguchi, L., Donnell, D., Mugo, N. R., Bukusi, E. A., Katabira, E., Asiimwe, S., Morton, J., Morrison, S., Haugen, H., Mujugira, A., Haberer, J. E., Ware, N. C., Wyatt, M. A., … Hendrix, C. (2017). Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: Uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Research, 1, https://doi.org/https://doi.org/10.12688/gatesopenres.12752.2
- Heffron, R., Pintye, J., Matthews, L. T., Weber, S., & Mugo, N. (2016). PrEP as peri-conception HIV prevention for women and men. Current HIV/AIDS Reports, 13(3), 131–139. https://doi.org/https://doi.org/10.1007/s11904-016-0312-1
- Hull, S. J., Bowleg, L., Perez, C., & Sichone-Cameron, M. (2017). Psychosocial and environmental factors affecting Black women’s consideration of PrEP as a viable prevention tool: Implications for strategic communication abstract 4038.0. APHA. https://apha.confex.com/apha/2017/meetingapp.cgi/Paper/376849
- Joseph Davey, D. L., Pintye, J., Baeten, J. M., Aldrovandi, G., Baggaley, R., Bekker, L. G., Celum, C., Chi, B. H., Coates, T. J., Haberer, J. E., Heffron, R., Kinuthia, J., Matthews, L. T., McIntyre, J., Moodley, D., Mofenson, L. M., Mugo, N., Myer, L., Mujugira, A., … John-Stewart, G. (2020). Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: Where are we now and where are we heading? Journal of the International AIDS Society, 23(1), e25426. https://doi.org/https://doi.org/10.1002/jia2.25426. John Wiley and Sons Inc.
- Keating, M. A., Hamela, G., Miller, W. C., Moses, A., Hoffman, I. F., & Hosseinipour, M. C. (2012). High hiv incidence and sexual behavior change among pregnant women in Lilongwe, Malawi: Implications for the risk of hiv acquisition. PLoS ONE, 7(6), e39109. https://doi.org/https://doi.org/10.1371/journal.pone.0039109.
- Kourtis, A. P., Wiener, J., Wang, L., Fan, B., Shepherd, J. A., Chen, L., Liu, W., Shepard, C., Wang, L., Wang, A., & Bulterys, M. (2018). Tenofovir disoproxil fumarate use during pregnancy and infant bone health. Pediatric Infectious Disease Journal, 37(11)2018, e264–e268. https://doi.org/https://doi.org/10.1097/INF.0000000000002152
- Kwakwa, H. A., Bessias, S., Sturgis, D., Mvula, N., Wahome, R., Coyle, C., & Flanigan, T. P. (2016). Attitudes toward HIV pre-exposure prophylaxis in a United States urban clinic population. AIDS and Behavior, 20(7), 1443–1450. https://doi.org/https://doi.org/10.1007/s10461-016-1407-9
- Magnus, M., Phillips, G., Kuo, I., Peterson, J., Rawls, A., West-Ojo, T., Jia, Y., Opoku, J., & Greenberg, A. E. (2014). HIV among women in the District of Columbia: An evolving epidemic? AIDS and Behavior, 18(3), 256-265. https://doi.org/https://doi.org/10.1007/s10461-013-0514-0
- Mirochnick, M., Taha, T., Kreitchmann, R., Nielsen-Saines, K., Kumwenda, N., Joao, E., Pinto, J., Santos, B., Parsons, T., Kearney, B., Emel, L., Herron, C., Richardson, P., Hudelson, S. E., Eshleman, S. H., George, K., Fowler, M. G., Sato, P., Mofenson, L., & HPTN 057 Protocol Team. (2014). Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life. JAIDS Journal of Acquired Immune Deficiency Syndromes, 65(1), 33–41. https://doi.org/https://doi.org/10.1097/QAI.0b013e3182a921eb
- Mofenson, L. M., Baggaley, R. C., & Mameletzis, I. (2017). Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding. AIDS, 31(2), 213–232. https://doi.org/https://doi.org/10.1097/QAD.0000000000001313
- Moodley, D., Esterhuizen, T. M., Pather, T., Chetty, V., & Ngaleka, L. (2009). High HIV incidence during pregnancy: Compelling reason for repeat HlV testing. AIDS, 23(10), 1255–1259. https://doi.org/https://doi.org/10.1097/QAD.0b013e32832a5934
- Mugo, N. R., Heffron, R., Donnell, D., Wald, A., Were, E. O., Rees, H., Celum, C., Kiarie, J. N., Cohen, C. R., Kayintekore, K., & Baeten, J. M. (2011). Increased risk of HIV-1 transmission in pregnancy: A prospective study among African HIV-1-serodiscordant couples. AIDS (London, England), 25(15), 1887–1895. https://doi.org/https://doi.org/10.1097/QAD.0b013e32834a9338
- Murnane, P. M., Celum, C., Mugo, N., Campbell, J. D., Donnell, D., Bukusi, E., Mujugira, A., Tappero, J., Kahle, E. M., Thomas, K. K., Baeten, J. M., & Partners PrEP Study Team. (2013). Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: Subgroup analyses from a randomized trial. AIDS (London, England), 27(13), 2155–2160. https://doi.org/https://doi.org/10.1097/QAD.0b013e3283629037
- Nachega, J. B., Uthman, O. A., Mofenson, L. M., Anderson, J. R., Kanters, S., Renaud, F., Ford, N., Essajee, S., Doherty, M. C., & Mills, E. J. (2017). Safety of tenofovir disoproxil fumarate-based antiretroviral therapy regimens in pregnancy for HIV-infected women and their infants: A systematic review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76(1), 1–12. https://doi.org/https://doi.org/10.1097/qai.0000000000001359
- Ojikutu, B. O., Bogart, L. M., Higgins-Biddle, M., Dale, S. K., Allen, W., Dominique, T., & Mayer, K. H. (2018). Facilitators and barriers to pre-exposure prophylaxis (PrEP) use among black individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS and Behavior, 22(11), 3576–3587. https://doi.org/https://doi.org/10.1007/s10461-018-2067-8
- Onah, H. E., Iloabachie, G. C., Obi, S. N., Ezugwu, F. O., & Eze, J. N. (2002). Nigerian male sexual activity during pregnancy. International Journal of Gynaecology and Obstetrics, 76(2), 219-223.
- Patel, A. S., Goparaju, L., Sales, J. M., Mehta, C. C., Blackstock, O. J., Seidman, D., Ofotokun, I., Kempf, M. C., Fischl, M. A., Golub, E. T., Adimora, A. A., French, A. L., Dehovitz, J., Wingood, G., Kassaye, S., & Sheth, A. N. (2019). Brief report: PrEP eligibility among at-risk women in the Southern United States: Associated factors, awareness, and acceptability. JAIDS Journal of Acquired Immune Deficiency Syndromes, 80(5), 527–532. https://doi.org/https://doi.org/10.1097/QAI.0000000000001950
- Petroll, A. E., Walsh, J. L., Owczarzak, J. L., McAuliffe, T. L., Bogart, L. M., & Kelly, J. A. (2017). PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS and Behavior, 21(5), 1256–1267. https://doi.org/https://doi.org/10.1007/s10461-016-1625-1
- Pintye, J., Baeten, J. M., Celum, C., Mugo, N., Ngure, K., Were, E., Bukusi, E. A., John-Stewart, G., & Heffron, R. A. (2017). Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: A prospective study. The Journal of Infectious Diseases, 216(12), 1561–1568. https://doi.org/https://doi.org/10.1093/infdis/jix542
- Salvadori, N., Fan, B., Teeyasoontranon, W., Ngo-Giang-Huong, N., Phanomcheong, S., Luvira, A., Puangsombat, A., Suwannarat, A., Srirompotong, U., Putiyanun, C., Cressey, T. R., Decker, L., Khamduang, W., Harrison, L., Tierney, C., Shepherd, J. A., Kourtis, A. P., Bulterys, M., Siberry, G. K., … Kham, C. (2018). Maternal and infant bone mineral density 1 year after delivery in a randomized, controlled trial of maternal tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus. Clinical Infectious Diseases, 144(1), 144–150. https://doi.org/https://doi.org/10.1093/cid/ciy982
- SAS 9.4 Software | SAS. (n.d.). Retrieved May 18, 2020, from https://www.sas.com/en_us/software/sas9.html
- Smith, D. K., van Handel, M., & Grey, J. (2018). Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Annals of Epidemiology, 28(12), 850–857.e9. https://doi.org/https://doi.org/10.1016/j.annepidem.2018.05.003
- AIDSinfo. (n.d.). Tenofovir disoproxil fumarate (Viread, TDF) | nucleoside and nucleotide analogue reverse transcriptase inhibitors | perinatal. Retrieved October 22, 2019, from https://aidsinfo.nih.gov/guidelines/html/3/perinatal/197/tenofovir-disoproxil-fumarate–viread–tdf-
- Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., Mutanhaurwa, R., Chirwa, L. I., Kasonde, M., Abebe, D., Buliva, E., Gvetadze, R. J., Johnson, S., Sukalac, T., Thomas, V. T., … TDF2 Study Group. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. https://doi.org/https://doi.org/10.1056/NEJMoa1110711
- Thomson, K. A., Hughes, J., Baeten, J. M., John-Stewart, G., Celum, C., Cohen, C. R., Ngure, K., Kiarie, J., Mugo, N., & Heffron, R. (2018). Increased risk of female HIV-1 acquisition throughout pregnancy and postpartum: A prospective per-coital act analysis among women with HIV-1 infected partners. The Journal of Infectious Diseases, 218(1), 16–25. https://doi.org/https://doi.org/10.1093/infdis/jiy113
- Willie, T., Kershaw, T., Campbell, J. C., & Alexander, K. A. (2017). Intimate partner violence and PrEP acceptability among low-income, young black women: Exploring the mediating role of reproductive coercion. AIDS and Behavior, 21(8), 2261–2269. https://doi.org/https://doi.org/10.1007/s10461-017-1767-9
- World Health Organization. (2017). WHO technical brief: Preventing HIV during pregnancy and breastfeeding in the context of pre-exposure prophylaxis (PrEP). http://apps.who.int/bookorders
- Yzer, M. (2012). The integrative model of behavioral prediction as a tool for designing health messages. In Health communication message design: Theory and practice (pp. 21–40). https://books.google.com/books?hl=en&lr=&id=9(5zAwAAQBAJ&oi=fnd&pg=PA21&dq=Yzer,+M.+(2012).+The+integrative+model+of+behavioral+prediction+as+a+tool+for+designing+health+messages.+Health+communication+message+design:+Theory+and+practice,+21-40.&ots=J4qoXe